These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29699374)

  • 1. Inhibitory Effects of Arsenic Trioxide and Thalidomide on Angiogenesis and Vascular Endothelial Growth Factor Expression in Leukemia Cells.
    Mohammadi Kian M; Mohammadi S; Tavallaei M; Chahardouli B; Rostami S; Zahedpanah M; Ghavamzadeh A; Nikbakht M
    Asian Pac J Cancer Prev; 2018 Apr; 19(4):1127-1134. PubMed ID: 29699374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental study of the anti-tumor effect of arsenic trioxide or thalidomide alone and combination of both for treatment of myelodysplastic syndrome model].
    Lu J; Jin J; Xu WL
    Zhonghua Er Ke Za Zhi; 2006 Mar; 44(3):228-33. PubMed ID: 16624066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Vascular Endothelial Growth Factor Effects of Sorafenib and Arsenic Trioxide in Acute Myeloid Leukemia Cell Lines.
    Haghi A; Mohammadi S; Heshmati M; Ghavamzadeh A; Nikbakht M
    Asian Pac J Cancer Prev; 2017 Jun; 18(6):1655-1661. PubMed ID: 28670885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted inhibition of VEGF-modulated survival and arsenic sensitivity in acute myeloid leukemia (AML).
    Ding Y; Zhu X; Li Y; Fei J; Zhang Y
    Hematology; 2012 May; 17(3):157-62. PubMed ID: 22664115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin Combined with Thalidomide Reduces Expression of
    Mohammadi Kian M; Salemi M; Bahadoran M; Haghi A; Dashti N; Mohammadi S; Rostami S; Chahardouli B; Babakhani D; Nikbakht M
    Drug Des Devel Ther; 2020; 14():185-194. PubMed ID: 32021103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mechanism of synergistic effects of arsenic trioxide and rapamycin in acute myeloid leukemia cell lines lacking typical t(15;17) translocation.
    Dembitz V; Lalic H; Ostojic A; Vrhovac R; Banfic H; Visnjic D
    Int J Hematol; 2015 Jul; 102(1):12-24. PubMed ID: 25758096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA-21 regulates arsenic-induced anti-leukemia activity in myelogenous cell lines.
    Gu J; Zhu X; Li Y; Dong D; Yao J; Lin C; Huang K; Hu H; Fei J
    Med Oncol; 2011 Mar; 28(1):211-8. PubMed ID: 20143188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thioredoxin-1 inhibitor PX-12 induces human acute myeloid leukemia cell apoptosis and enhances the sensitivity of cells to arsenic trioxide.
    Tan Y; Bi L; Zhang P; Wang F; Lin F; Ni W; Wu J; Jiang L
    Int J Clin Exp Pathol; 2014; 7(8):4765-73. PubMed ID: 25197347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Vascular Endothelial Growth Factor Targeting by Curcumin and Thalidomide in Acute Myeloid Leukemia Cells.
    Salemi M; Mohammadi S; Ghavamzadeh A; Nikbakht M
    Asian Pac J Cancer Prev; 2017 Nov; 18(11):3055-3061. PubMed ID: 29172279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic Trioxide and Thalidomide Combination Induces Autophagy Along with Apoptosis in Acute Myeloid Cell Lines.
    Mohammadi Kian M; Haghi A; Salami M; Chahardouli B; Rostami SH; Malekzadeh K; Kamranzadeh Foumani H; Mohammadi S; Nikbakht M
    Cell J; 2020 Jul; 22(2):193-202. PubMed ID: 31721534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of Mcl-1 through GSK-3β activation contributes to arsenic trioxide-induced apoptosis in acute myeloid leukemia cells.
    Wang R; Xia L; Gabrilove J; Waxman S; Jing Y
    Leukemia; 2013 Feb; 27(2):315-24. PubMed ID: 22751450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic killing effects of homoharringtonine and arsenic trioxide on acute myeloid leukemia stem cells and the underlying mechanisms.
    Tan M; Zhang Q; Yuan X; Chen Y; Wu Y
    J Exp Clin Cancer Res; 2019 Jul; 38(1):308. PubMed ID: 31307525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanisms of arsenic trioxide induced tumor cell apoptosis in myelodysplastic syndrome mice model in vivo].
    Lu J; Jin J
    Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):782-6. PubMed ID: 17229386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Synergistic lethal effect of combined treatment of arsenic trioxide and aclacinomycin on human acute myeloid leukemia cell line KG-1a].
    Ye YB; Xu XJ; Chen YH; Zhang MW; Qiu DF; Guo ZW; He HQ
    Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):256-262. PubMed ID: 28550664
    [No Abstract]   [Full Text] [Related]  

  • 15. The optimal dose of arsenic trioxide induced opposite efficacy in autophagy between K562 cells and their initiating cells to eradicate human myelogenous leukemia.
    Guo Z; Meng M; Geng S; Du Z; Zheng Y; Yao J; Li Z; Han G; Lin H; Du G
    J Ethnopharmacol; 2017 Jan; 196():29-38. PubMed ID: 27965050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic Trioxide and Venetoclax Synergize against AML Progenitors by ROS Induction and Inhibition of Nrf2 Activation.
    Hoang DH; Buettner R; Valerio M; Ghoda L; Zhang B; Kuo YH; Rosen ST; Burnett J; Marcucci G; Pullarkat V; Nguyen LXT
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration in miRNA gene expression pattern in acute promyelocytic leukemia cell induced by arsenic trioxide: a possible mechanism to explain arsenic multi-target action.
    Ghaffari SH; Bashash D; Dizaji MZ; Ghavamzadeh A; Alimoghaddam K
    Tumour Biol; 2012 Feb; 33(1):157-72. PubMed ID: 22072212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artesunate possesses anti-leukemia properties that can be enhanced by arsenic trioxide.
    Li Y; Feng L; Li Y; Jiang W; Shan N; Wang X
    Leuk Lymphoma; 2014 Jun; 55(6):1366-72. PubMed ID: 23906016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells.
    Martelli MP; Gionfriddo I; Mezzasoma F; Milano F; Pierangeli S; Mulas F; Pacini R; Tabarrini A; Pettirossi V; Rossi R; Vetro C; Brunetti L; Sportoletti P; Tiacci E; Di Raimondo F; Falini B
    Blood; 2015 May; 125(22):3455-65. PubMed ID: 25795919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethacrynic acid and a derivative enhance apoptosis in arsenic trioxide-treated myeloid leukemia and lymphoma cells: the role of glutathione S-transferase p1-1.
    Wang R; Liu C; Xia L; Zhao G; Gabrilove J; Waxman S; Jing Y
    Clin Cancer Res; 2012 Dec; 18(24):6690-701. PubMed ID: 23082001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.